InvestorsHub Logo
Followers 16
Posts 4650
Boards Moderated 0
Alias Born 08/11/2015

Re: RFB post# 2789

Tuesday, 05/23/2017 4:30:38 PM

Tuesday, May 23, 2017 4:30:38 PM

Post# of 18220
"They have no operations"

They just got marketing approval yesterday. They're about to start operations very soon. Go ahead and buy the stock in a few weeks after they've started selling. It doesn't bother me. I'm going to continue to hold on to my shares (and I bought more today).

"They're diluting heavily"

This is not true. There is some dilution left, yes. But it's nothing out of the ordinary. The most recent q-10 looks just fine to me in terms of the notes payable section. Looks a lot better than the notes payable section in the 10-k. You need to have dilution in a pre revenue biotech. Period. How can the company fund operations BEFORE revenues kick in WITHOUT dilution? Can you explain that please? It's simply impossible as you know. Once revenues start, dilution will be a thing of the past.